Add BrightSurf on Google Email

The Lancet


Alcohol must be given political priority

A global Framework Convention on Alcohol Control is seen as crucial to addressing the alcohol-related health crisis. Non-governmental organisations and governments must work together to overcome industry resistance and generate political priority for alcohol control efforts.

SourceThe Lancet_DELETED·JournalThe Lancet·DateJun 25, 2009

International framework convention on alcohol control, similar to that for tobacco, is needed to confront alcohol disease burden

The authors emphasize the need for an effective international response to address alcohol-related harm, citing inadequate policies and industry influence as major obstacles. Cost-effective interventions exist but require scaling up; governments, NGOs, and academia must work together to develop and implement policies.

SourceThe Lancet_DELETED·JournalThe Lancet·DateJun 25, 2009

Weight-loss surgery could lower cancer risk in obese women

A recent study suggests that weight-loss surgery could be associated with reduced cancer risk in obese women, with a 42% decrease in first-time cancers over 10 years. However, the surgery had no effect on cancer incidence in men. The findings indicate that bariatric surgery may have broader benefits for women's cancer prevention.

SourceThe Lancet_DELETED·JournalThe Lancet Oncology·DateJun 23, 2009

Chances of surviving rare pregnancy-related tumor depends on how long before presentation the related pregnancy occurred

Survival rates for placental-site trophoblastic tumours (PSTTs) vary depending on how long ago the related pregnancy occurred. The study found that patients with stage I disease had a 10-year probability of overall survival of 90%, while those with recurrent disease or disease resistant to treatment had poor survival.

SourceThe Lancet_DELETED·JournalThe Lancet·DateJun 22, 2009

NICE approves use of lenalidomide in patients with multiple myeloma who have received 2 or more previous therapies

The UK's National Institute for Health and Clinical Excellence (NICE) has approved the use of lenalidomide in patients with multiple myeloma who have received two or more previous therapies. The approval is based on robust data showing that lenalidomide can increase survival by over three months compared to dexamethasone.

SourceThe Lancet_DELETED·JournalThe Lancet Oncology·DateJun 17, 2009

Addition of HPV test to UK cervical screening program no better at detecting cervical cancer

A study published in The Lancet Oncology found that combining HPV testing with routine liquid-based cytology (LBC) screening in the UK did not increase the detection of cervical cancer. However, HPV testing detected cases of precancerous cervical cells in the first round of screening, but this effect was not sustained over two rounds.

SourceThe Lancet_DELETED·JournalThe Lancet Oncology·DateJun 17, 2009

A strong future for women in medicine

Despite progress, women still face underrepresentation in senior academic roles and limited flexible working support. The medical profession should be secure with a merit-based selection process, providing a larger talent pool for both women and men.

SourceThe Lancet_DELETED·JournalThe Lancet·DateJun 11, 2009

Rosiglitazone (Avandia) used in combination therapy for type 2 diabetes does not increase risk of cardiovascular disease or death but increases heart failure, and fractures in women

A study found that rosiglitazone, used in combination with standard diabetes treatments, does not increase cardiovascular disease or death risk but doubles the risk of heart failure and fractures, mainly in women. The study included 4447 patients with type 2 diabetes.

SourceThe Lancet_DELETED·JournalThe Lancet·DateJun 5, 2009

UK's appalling failure to tackle HIV

The UK's HIV strategy is being heavily criticized due to its inadequate approach to testing and diagnosis. An estimated 77,000 people are living with HIV in the UK, with 21,000 unaware of their positive status. A third of those diagnosed late could have benefited from treatment if identified earlier.

SourceThe Lancet_DELETED·JournalThe Lancet·DateMay 28, 2009

Women with gestational diabetes during pregnancy have a substantial and persistently elevated risk of type 2 diabetes post birth

A recent study found that women who develop gestational diabetes during pregnancy are seven-and-a-half times more likely to develop type 2 diabetes post-birth. This increased risk remains for several years, emphasizing the need for continued monitoring and intervention. Early identification and treatment of related factors, such as lip...

SourceThe Lancet_DELETED·JournalThe Lancet·DateMay 21, 2009

Putting Influenza A H1N1 in its place

The Lancet Editorial highlights the balanced media coverage of the H1N1 outbreak, noting its relative morbidity and mortality. The article also commends health authorities for their measured responses to the crisis, preparing them for a potentially more devastating pandemic.

SourceThe Lancet_DELETED·JournalThe Lancet Infectious Diseases·DateMay 8, 2009